Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Mallinckrodt
Johnson and Johnson
Baxter
Moodys

Pharmaceutical companies with the most 'New Product Exclusivity' drugs

This chart shows the companies which have received the most New Product exclusivities in the past five years.

New Product Development is one of the categories for which the FDA grants three years of exclusivity for 'New Clinical Investigations.'

Alternate categories worth of three years of protection include identifying a New Patient Population, New Dosage Form, or New Strength.

The companies with the most New Product exclusivities are:

Back to Pharmaceutical Industry Infographics

Make Better Decisions: Try a trial or see plans & pricing